@cherberts1 Is this comparable to what @BramDL coined pathway complexity: https://t.co/5VvAnPYkNI?
RT @BramDL: Delighted to share our recent publication: Increased Pathway Complexity Is a Prognostic Biomarker in Metastatic Castration-Resi…
RT @BramDL: Delighted to share our recent publication: Increased Pathway Complexity Is a Prognostic Biomarker in Metastatic Castration-Resi…
RT @piet_ost: Trying to summarize the heterogeneous genomic landscape in #prostatecancer using “Pathway Complexity” as a prognostic marker…
RT @BramDL: Delighted to share our recent publication: Increased Pathway Complexity Is a Prognostic Biomarker in Metastatic Castration-Resi…
RT @BramDL: Delighted to share our recent publication: Increased Pathway Complexity Is a Prognostic Biomarker in Metastatic Castration-Resi…
RT @BramDL: Delighted to share our recent publication: Increased Pathway Complexity Is a Prognostic Biomarker in Metastatic Castration-Resi…
RT @AUrbanucci: @BramDL et al., https://t.co/Ku0CLMBFNP in our special issue https://t.co/HeTeYhxIWD propose #pathway #complexity index (PC…
@BramDL et al., https://t.co/Ku0CLMBFNP in our special issue https://t.co/HeTeYhxIWD propose #pathway #complexity index (PCI) discernible from #ctDNA mutations in 13 pathways. High PCI score is associated with poor outcomes to #ARSI in #metastatic #CRPC #p
RT @BramDL: Delighted to share our recent publication: Increased Pathway Complexity Is a Prognostic Biomarker in Metastatic Castration-Resi…
RT @piet_ost: Trying to summarize the heterogeneous genomic landscape in #prostatecancer using “Pathway Complexity” as a prognostic marker…
RT @BramDL: Delighted to share our recent publication: Increased Pathway Complexity Is a Prognostic Biomarker in Metastatic Castration-Resi…
RT @BramDL: Delighted to share our recent publication: Increased Pathway Complexity Is a Prognostic Biomarker in Metastatic Castration-Resi…
Delighted to share our recent publication: Increased Pathway Complexity Is a Prognostic Biomarker in Metastatic Castration-Resistant #ProstateCancer https://t.co/MWLruNPADB via @Cancers_MDPI [1/8] https://t.co/bTTsGqC1P6
RT @piet_ost: Trying to summarize the heterogeneous genomic landscape in #prostatecancer using “Pathway Complexity” as a prognostic marker…
RT @piet_ost: Trying to summarize the heterogeneous genomic landscape in #prostatecancer using “Pathway Complexity” as a prognostic marker…
RT @piet_ost: Trying to summarize the heterogeneous genomic landscape in #prostatecancer using “Pathway Complexity” as a prognostic marker…
RT @piet_ost: Trying to summarize the heterogeneous genomic landscape in #prostatecancer using “Pathway Complexity” as a prognostic marker…
Trying to summarize the heterogeneous genomic landscape in #prostatecancer using “Pathway Complexity” as a prognostic marker by @BramDL https://t.co/Kk1NM0LA8m